$78.45 0.1%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 256 -4.8%
Sentiment 60 0%
Webpage traffic 5,365,000 5.9%
Employee Rating 85 0%
Google Adspend $644,548 -0.6%
Google Trends 20 -31%
Linkedin Employees 27,643 N/A
Lobbying Cost $17,000 0%
Patents 872 0.1%
4chan Mentions -100%
Facebook Engagement 15,084 18.7%
Facebook followers 3,546,995 0.2%
Stocktwits Mentions 2 0%
Stocktwits Subscribers 3,836 0%
Tiktok Followers 1,000,000 N/A
Twitter Followers 76,964 -0%
Youtube Subscribers 138,000 0%
Instagram Followers 183,820 0%
News Mentions 1 -50%
Reddit Mentions 4 0%
Business outlook 77 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Colgate-Palmolive

Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries around the world (international sales account for about 75% of its consolidated total, including approximately 50% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.

Price $78.45
Target Price Sign up
Market Cap $64.1B
Dividend Yield 0.0247
Industry Consumer Packaged Goods

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '234.92B2.04B2.88B708M1.03B
Q2 '234.82B2.04B2.79B502M974M
Q1 '234.77B2.06B2.71B372M1.04B
Q4 '224.63B2.06B2.57B5M1.78B
Q3 '224.46B1.91B2.55B618M947M

Insider Transactions

Tsourapas Panagiotis filed to sell 12,371 shares at $77.8.
November 30 '23
Tsourapas Panagiotis filed to sell 12,292 shares at $75.4.
November 14 '23
Kooyman John W filed to sell 5,347 shares at $75.1.
November 7 '23
CAHILL JOHN T filed to sell 24,686 shares at $74.9.
November 7 '23
NORRINGTON LORRIE M filed to sell 31,307 shares at $74.6.
November 6 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.